mAb therapies (Perseus Proteomics)

N/A

Report date: 2025/03/20 14:45:40

Base Information

Drug NamemAb therapies (Perseus Proteomics)
Drug Alias Namemonoclonal antibody therapies (Perseus Proteomics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPerseus Proteomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPerseus Proteomics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A